This paper presents the CLEAR framework as a way to maintain scientific rigor when rapidly appraising literature in the context of Medical Affairs
As the demand for increased levels of evidence grows, so too has the role of Non-Company Sponsored Research (NCSR). This position paper by the MAPS Evidence Generation Domain provides key considerations to ensure NCSR delivers strategic value.
Many Medical Affairs professionals lack holistic understanding of the business context in which medicines are developed or even view commercial aspects as incompatible with scientific and medical values. This paper provides fundamental understanding of business priorities, empowering Medical Affairs to contribute effectively to enterprise-wide
Guide and templates for Medical Affairs input into MedTech Health Hazard Assessment
Guide and templates for Medical Affairs input into MedTech Health Hazard Assessment
The Medical Affairs Professional Society (MAPS) is pleased to share the 2025 Medical Affairs Launch Readiness and Execution Benchmark Report. This report is based on findings from 28 leading organizations across Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors, and reflects broad leadership thinking about the role of Medical in product launch, current and future challenges, and the capabilities required to succeed in the future.
In this webinar, a panel of experts will share their current experiences, challenges, and perspectives on tracking and interpreting the broader impact of scientific content.
In this On-Demand webinar, we explore the recently released MAPS Standards & Guidance (S+G) documents, “Measuring Value and Impact in Medical Affairs” and “Strategic Medical Planning Guide.”
In this On-Demand webinar, we explore the recently released MAPS Standards & Guidance (S+G) documents, “Measuring Value and Impact in Medical Affairs” and “Strategic Medical Planning Guide.”
Join experts from Enago Life Sciences to learn best practices for navigating the balance between efficiency and authority in expedited publishing.